Blood transfusion and surgery
Concern about the acquired immune deficiency syndrome (AIDS) has resulted in major changes in blood transfusion practice in the United States and its impact is now making itself felt in Britain. Although the risk of acquiring AIDS by blood transfusion seems to be remote, and certainly less than that of developing hepatitis, it has provoked a timely reappraisal of attitudes to transfusion. Recent advances in laboratory techniques have reduced the time taken to perform a safe cross match to 30 to 40 minutes. Thus provided the patient has been grouped and screened for antibodies any surgical procedure that seldom causes loss of more than 20% of the total blood volume should no longer routinely be covered by two or three units of cross matched blood.
Ten years ago Sykes recommended that losses of this order should be replaced with non-sanguineous fluids.' But this has not happened, chiefly because cross matched blood has usually been readily available. Nevertheless, cross matching of blood does nothing to reduce the incidence of the four or more serious diseases transmitted by viruses, nor of anaphylactic and delayed haemolytic reactions.2 The development of crystalline haemoglobin solutions and perfluorocarbons has not yet got to the stage where either of them has advantages over plasma or plasma substitutes.
Studies from different countries of the ratio of blood cross matched to blood transfused during routine operations show that practice is remarkably similar for procedures for which two or three units of blood are cross matched but seldom used.3-6 Seshadri and his colleagues have instituted a maximum order for blood for all routine elective operations, and this is adhered to unless the patient has antibodies or there are other unusual circumstances.5 Arguably it is time for British hospitals, which at present have a service based on arbitrary request, to adopt a similar approach.
There has never been any justification for transfusing a patient before elective surgery simply on the grounds that it might be expedient, and now patient resistance will probably, and rightly, put a stop to it. The accepted lower limit of haemoglobin of 10 g/dl should not be abandoned: it represents a loss of about 25% of the oxygen carrying capacity of the blood and no anaesthetist can guarantee not to let his or her patient's cardiac output fall during the operation. Concentrations below 10 g/dl are accompanied by a progressive increase in the bleeding time,7 and below 9 g/dl the compensatory increase in dissociation of oxyhaemoglobin will no longer prevent a decrease in cardiac output. 8 Demand for designated blood, either from relatives or by one of the methods making use of autologous blood,' is increasing. Its application is necessarily restricted but it may prove useful in paediatric surgery and for operations that have a relatively predictable blood loss. Blood taken from relatives and by the so called predeposit autologous method (by which blood is taken from the patient days or even weeks preoperatively) is not popular with transfusion staff, who are understandably reluctant to see a two tier system develop.1' Yet, if clinicians become responsible for taking, storing, and administering such blood the present high standards of the transfusion service seem unlikely to be maintained. This problem may be overcome if autologous blood-obtained either by salvage autotransfusion or by deliberate haemodilution-is used. In salvage autotransfusion blood lost during surgery is collected and reinfused and this method deserves wider application than it has so far achieved. Deliberate haemodilution entails bleeding patients at the induction of anaesthesia and maintaining normovolaemia by infusion of clear fluids. This method is particularly suitable for patients whose haemoglobin concentrations are above the normal range, for high concentrations, in contrast to low ones, are known to be associated with increased surgical morbidity and mortality.' '5 The patient is bled until the packed cell volume reaches a predetermined level, usually 35%, and the blood is anticoagulated and then reinfused to cover subsequent operative loss. 6
In the United States active transfusion committees are a requirement of the Joint Commission on Accreditation of Hospitals. 7 In the current ferment of public and professional concern about blood transfusion, hospitals in Britain would do well to follow this practice. If they drag their feet this may prove to be an aspect of clinical practice that will be called to account by their new managers.
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